Cargando…

Myotonic Dystrophy type 1 cells display impaired metabolism and mitochondrial dysfunction that are reversed by metformin

Myotonic dystrophy type 1 (DM1; MIM #160900) is an autosomal dominant disorder, clinically characterized by progressive muscular weakness and multisystem degeneration. The broad phenotypes observed in patients with DM1 resemble the appearance of a multisystem accelerated aging process. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales:	García-Puga, Mikel, Saenz-Antoñanzas, Ander, Fernández-Torrón, Roberto, de Munain, Adolfo Lopez, Matheu, Ander
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7185118/ https://www.ncbi.nlm.nih.gov/pubmed/32310829 http://dx.doi.org/10.18632/aging.103022

Ejemplares similares

Targeting Myotonic Dystrophy Type 1 with Metformin
por: García-Puga, Mikel, et al.
Publicado: (2022)

Senescence plays a role in myotonic dystrophy type 1
por: García-Puga, Mikel, et al.
Publicado: (2022)

Muscle wasting in myotonic dystrophies: a model of premature aging
por: Mateos-Aierdi, Alba Judith, et al.
Publicado: (2015)

Leukocyte telomere length in patients with myotonic dystrophy type I: a pilot study
por: Wang, Youjin, et al.
Publicado: (2019)

Social cognition in myotonic dystrophy type 1: Specific or secondary impairment?
por: Labayru, Garazi, et al.
Publicado: (2018)

SOX9 promotes tumor progression through the axis BMI1-p21(CIP)
por: Aldaz, Paula, et al.
Publicado: (2020)

Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1
por: Labayru, Garazi, et al.
Publicado: (2019)

Towards precision medicine: linking genetic and cellular heterogeneity in gastric cancer
por: Carrasco-Garcia, Estefania, et al.
Publicado: (2018)

CRISPR/Cas9 Deletion of SOX2 Regulatory Region 2 (SRR2) Decreases SOX2 Malignant Activity in Glioblastoma
por: Saenz-Antoñanzas, Ander, et al.
Publicado: (2021)

Chaperone-Mediated Autophagy Controls Proteomic and Transcriptomic Pathways to Maintain Glioma Stem Cell Activity
por: Auzmendi-Iriarte, Jaione, et al.
Publicado: (2022)

Relevance of oxidative stress and inflammation in frailty based on human studies and mouse models
por: Álvarez-Satta, María, et al.
Publicado: (2020)

CD8(+) T cells are increased in the subventricular zone with physiological and pathological aging
por: Moreno‐Valladares, Manuel, et al.
Publicado: (2020)

CD8(+) T cells are present at low levels in the white matter with physiological and pathological aging
por: Moreno-Valladares, Manuel, et al.
Publicado: (2020)

Age‐related cognitive decline in myotonic dystrophy type 1: An 11‐year longitudinal follow‐up study
por: Labayru, Garazi, et al.
Publicado: (2019)

Delay of EGF-Stimulated EGFR Degradation in Myotonic Dystrophy Type 1 (DM1)
por: Alegre-Cortés, Eva, et al.
Publicado: (2022)

Myotonic dystrophy
por: Patterson, VH
Publicado: (1990)

Unravelling the impact of frontal lobe impairment for social dysfunction in myotonic dystrophy type 1
por: Morin, Alexandre, et al.
Publicado: (2022)

Hypogonadism and erectile dysfunction in myotonic dystrophy type 1
por: PERIC, STOJAN, et al.
Publicado: (2013)

Six Serum miRNAs Fail to Validate as Myotonic Dystrophy Type 1 Biomarkers
por: Fernandez-Costa, Juan M., et al.
Publicado: (2016)

Transcriptional signatures of synaptic vesicle genes define myotonic dystrophy type I neurodegeneration
por: Jimenez‐Marin, Antonio, et al.
Publicado: (2021)

Metabolic impairments in patients with myotonic dystrophy type 2
por: VUJNIC, MILORAD, et al.
Publicado: (2018)

PMON17 Impaired cortisol regulation in Myotonic dystrophy
por: Mittal, Ashima, et al.
Publicado: (2022)

Liquid Biopsy in Glioblastoma: Opportunities, Applications and Challenges
por: Saenz-Antoñanzas, Ander, et al.
Publicado: (2019)

Cancer and Myotonic Dystrophy
por: D’Ambrosio, Eleonora S., et al.
Publicado: (2023)

Characterization of a new small-molecule inhibitor of HDAC6 in glioblastoma
por: Auzmendi-Iriarte, Jaione, et al.
Publicado: (2020)

Shedding light on motor premanifest myotonic dystrophy type 1: A molecular, muscular and central nervous system follow‐up study
por: Garmendia, Joana, et al.
Publicado: (2022)

Resistance Exercise Training Rescues Mitochondrial Dysfunction in Skeletal Muscle of Patients with Myotonic Dystrophy Type 1
por: Di Leo, Valeria, et al.
Publicado: (2023)

SOX2 haploinsufficiency promotes impaired vision at advanced age
por: Moreno-Cugnon, Leire, et al.
Publicado: (2018)

Preclinical characterization of antagomiR-218 as a potential treatment for myotonic dystrophy
por: Cerro-Herreros, Estefanía, et al.
Publicado: (2021)

Desflurane anaesthesia in myotonic dystrophy
por: Gandhi, Ranju, et al.
Publicado: (2011)

Myotonic Dystrophy: An Anaesthetic Dilemma
por: Gupta, N, et al.
Publicado: (2009)

Cardiac involvement in myotonic dystrophy
por: Khalighi, Koroush, et al.
Publicado: (2015)

Steakhouse Syndrome in Myotonic Dystrophy
por: Ogasawara, Nobuhiko, et al.
Publicado: (2017)

Cutaneous findings in myotonic dystrophy
por: Kong, Ha Eun, et al.
Publicado: (2022)

Muscle Chloride Channel Dysfunction in Two Mouse Models of Myotonic Dystrophy
por: Lueck, John D., et al.
Publicado: (2007)

Multisystemic Impairments in 93 Chinese Patients With Myotonic Dystrophy Type 1
por: Li, Mao, et al.
Publicado: (2020)

Marathoning with myotonic dystrophy type 2 (proximal myotonic myopathy) and leukopenia
por: Finsterer, Josef, et al.
Publicado: (2017)

A new approach based on targeted pooled DNA sequencing identifies novel mutations in patients with Inherited Retinal Dystrophies
por: Ezquerra-Inchausti, Maitane, et al.
Publicado: (2018)

Open Bite Malocclusion and Orofacial Dysfunction in Patients with Myotonic Dystrophy Type 1 and Duchenne Muscular Dystrophy
por: Havner, Christina, et al.
Publicado: (2023)

Respiratory failure in myotonic dystrophy 1
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_jm7biea88ocd072s68ghvkf1e3